Finger Paul T, Harbour J William, Karcioglu Zeynel A
The New York Eye Cancer Center, New York, NY, USA.
Surv Ophthalmol. 2002 Jan-Feb;47(1):1-16. doi: 10.1016/s0039-6257(01)00279-x.
Children with retinoblastoma typically survive their cancer due to advances in early diagnosis and treatment. Despite this success, risk factors persist for metastasis that are thought to be related to patient age, sex, laterality, treatment, genetics, histopathology, and extraocular extension. This review has found that invasion of the uvea, orbit, and optic nerve continue to be the most important predictors of metastatic retinoblastoma. Bilaterality and delays in diagnosis are also important factors. We examine molecular and genetic studies that offer the potential of predicting which tumors are likely to metastasize, which will recur within the eye, and which will undergo senescence. In this review, we describe which clinical evaluations, genetic studies, and histopathologic evaluations of retrieved specimens are currently used widely. This review has been performed to help those caring for patients with retinoblastoma and to aid informed consent.
由于早期诊断和治疗方面的进展,视网膜母细胞瘤患儿通常能够战胜癌症。尽管取得了这一成功,但转移的风险因素依然存在,这些因素被认为与患者年龄、性别、病变侧别、治疗、遗传学、组织病理学以及眼外扩展有关。本综述发现,脉络膜、眼眶和视神经的侵犯仍然是转移性视网膜母细胞瘤最重要的预测指标。双侧性和诊断延迟也是重要因素。我们研究了分子和遗传学研究,这些研究提供了预测哪些肿瘤可能发生转移、哪些会在眼内复发以及哪些会发生衰老的潜力。在本综述中,我们描述了目前广泛使用的对获取标本的哪些临床评估、遗传学研究和组织病理学评估。进行本综述是为了帮助那些照顾视网膜母细胞瘤患者的人,并有助于获得知情同意。